Daniel Sanders

Daniel Sanders has a diverse work experience spanning multiple industries. Daniel currently holds the position of Chief Scientific Officer at Gwella, a specialist brand house focused on wellness products with novel fungi and plant-based ingredients. Prior to that, they worked as a Senior Scientist and Senior Management-European Union Lead at Albert Labs, where they focused on drug development and the extraction of psilocybin and psilocin analogs. Daniel also served as the Director of Research and Business Development at MaryGold Laboratories, overseeing testing in craft brewery beer and cannabis regulation. Daniel has a background in hemp industry development as the President of ARextracts. Additionally, they have held roles as Chief Research Officer at BlueRose Innovation Institute, Research Coordinator at Clinical Trials Inc., Nanotechnology Research Technician at the University of Arkansas at Little Rock, and Computer Technician at Staples Business Advantage. Daniel also has experience as a college tutor in physics, chemistry, and mathematics.

Daniel Sanders attended the University of Arkansas at Little Rock from 2011 to 2016, where they earned a Bachelor of Science degree in Genetics and Molecular Biotechnology.